Eli Lilly and Company today announced groundbreaking results from a Phase 3 clinical trial for its investigational triple agonist, retatrutide,…
Read More

Eli Lilly and Company today announced groundbreaking results from a Phase 3 clinical trial for its investigational triple agonist, retatrutide,…
Read More
For decades, the clinical hallmark of Alzheimer’s disease has been the progressive erosion of memory and cognitive function. However, emerging…
Read More
A collaborative research effort led by the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) and the Technical University of Dresden (TU Dresden) has pioneered…
Read More
Mars, a world sculpted by cosmic impacts and imbued with chemically aggressive soils, presents a formidable gauntlet for any potential…
Read More
The latest episode of the podcast "This Week in Virology" (TWiV), number 1293, released on February 1, 2026, delved into…
Read More
A multi-institutional research initiative, co-led by a physician-scientist at the University of Arizona College of Medicine – Tucson’s Sarver Heart…
Read More
Pharmaceutical R&D is at an inflection point, witnessing a profound transformation that challenges the historical dichotomy between small and large…
Read More
The scientific community has long recognized extra virgin olive oil (EVOO) as a foundational element of the Mediterranean diet, attributing…
Read More
The pursuit of dark matter, the elusive substance believed to constitute approximately 85 percent of the universe’s total matter, has…
Read More
At the bottom of some mezcal bottles sits one of the most recognizable curiosities in the world of spirits: a…
Read More